Rhinebeck Bancorp, Inc. current report, 26 May 2020

Rhinebeck Bancorp, Inc. Form 8-K Summary

Business Context and Reporting Period

Rhinebeck Bancorp, Inc. filed a Form 8-K reporting actions taken at its Annual Meeting of Stockholders held on May 26, 2020. The report was signed on May 27, 2020. The company’s common stock trades on Nasdaq under the symbol RBKB.

Key Financial Metrics and Capital Position

This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating and financial performance metrics.

Material Changes and Corporate Actions

  • Stockholders approved the Rhinebeck Bancorp, Inc. 2020 Equity Incentive Plan.
  • William C. Irwin and Michael J. Quinn were elected as directors, each for a three-year term or until a successor is elected and qualified.
  • Stockholders ratified the appointment of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2020.

Voting Results

ProposalForAgainst or WithholdAbstentionsBroker Non-Votes
William C. Irwin, director9,055,606501,396 withheldNot separately reported812,439
Michael J. Quinn, director9,417,036139,966 withheldNot separately reported812,439
2020 Equity Incentive Plan9,231,785306,34018,877812,439
Ratification of Wolf & Company, P.C.10,225,33454,01290,095Not reported

Guidance, Outlook, Risks, and Unusual Items

The filing provides no management guidance or business outlook and does not identify material contingencies or unusual financial items. The approved equity incentive plan may affect future equity-based compensation and share dilution; its detailed terms are incorporated by reference from the company’s April 21, 2020 definitive proxy statement.

Important Facts to Verify

  • Review the 2020 Equity Incentive Plan for authorized shares, award types, vesting provisions, and potential dilution.
  • Confirm the company’s subsequent disclosures regarding equity awards issued under the plan and related compensation expense.
  • Review later filings for financial performance, liquidity, capital, and any risks associated with the COVID-19 period.